Edward Conway

Dr. Edward Conway is a Professor in the Department of Medicine at the University of British Columbia (UBC) and Director of UBC’s Centre for Blood Research. He holds a Tier 1 Canada Research Chair in Endothelial Cell Biology. His research focuses on molecular mechanisms linking coagulation and innate immunity, particularly the tumor endothelial marker CD248 (endosialin). He has led international research groups, developed graduate programs, and collaborated with industry. His work bridges basic and clinical research to address cardiovascular diseases and thrombosis.

Research interests include the interplay between coagulation pathways, complement activation, and inflammatory responses in diseases like atherosclerosis, stroke, and diabetes. His studies on CD248 explore its role in inflammation, cancer, and vascular pathologies. Dr. Conway’s lab uses pre-clinical and clinical models to identify therapeutic targets.

• Education & Affiliations: Not explicitly detailed in available texts, but he is affiliated with the Centre for Blood Research and collaborates internationally (e.g., Belgium).
• Grants & Funding: Supported by CIHR, NSERC, and industry partnerships.
• Awards: Tier 1 Canada Research Chair (2009–present).

His 15 most recent publications (2012–2018) emphasize coagulation-inflammation cross-talk, CD248 biology, and complement regulation. Collaborations with global institutions enhance translational efforts. Dr. Conway mentors students in vascular biology and coagulation research.